Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

468 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interferon alpha in the treatment of polycythemia vera.
Lengfelder E, Berger U, Hehlmann R. Lengfelder E, et al. Among authors: hehlmann r. Ann Hematol. 2000 Mar;79(3):103-9. doi: 10.1007/s002770050563. Ann Hematol. 2000. PMID: 10803930 Review.
Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia. German AML Cooperative Group.
Lengfelder E, Reichert A, Schoch C, Haase D, Haferlach T, Löffler H, Staib P, Heyll A, Seifarth W, Saussele S, Fonatsch C, Gassmann W, Ludwig WD, Hochhaus A, Beelen D, Aul C, Sauerland MC, Heinecke A, Hehlmann R, Wörmann B, Hiddemann W, Büchner T. Lengfelder E, et al. Among authors: hehlmann r. Leukemia. 2000 Aug;14(8):1362-70. doi: 10.1038/sj.leu.2401843. Leukemia. 2000. PMID: 10942230 Clinical Trial.
Treatment of relapsed acute promyelocytic leukemia.
Lengfelder E, Gnad U, Büchner T, Hehlmann R. Lengfelder E, et al. Among authors: hehlmann r. Onkologie. 2003 Aug;26(4):373-9. doi: 10.1159/000072100. Onkologie. 2003. PMID: 12972706 Review.
Randomized study of the combination of hydroxyurea and interferon alpha versus hydroxyurea monotherapy during the chronic phase of chronic myelogenous leukemia (CML Study II). The German CML Study Group.
Hehlmann R, Heimpel H, Hossfeld DK, Hasford J, Kolb HJ, Löffler H, Pralle H, Queisser W, Hochhaus A, Tichelli A, Fett W, Schmitz N, Reiter A, Griesshammer M, Pfeifer W, Bümler M, Kamp T, Tobler A, Eimermacher H, Kuse R, Berger U, Ansari H. Hehlmann R, et al. Bone Marrow Transplant. 1996 May;17 Suppl 3:S21-4. Bone Marrow Transplant. 1996. PMID: 8769695 Clinical Trial.
Should a platelet limit of 600 x 10(9)/l be used as a diagnostic criterion in essential thrombocythaemia? An analysis of the natural course including early stages.
Lengfelder E, Hochhaus A, Kronawitter U, Höche D, Queisser W, Jahn-Eder M, Burkhardt R, Reiter A, Ansari H, Hehlmann R. Lengfelder E, et al. Among authors: hehlmann r. Br J Haematol. 1998 Jan;100(1):15-23. doi: 10.1046/j.1365-2141.1998.00529.x. Br J Haematol. 1998. PMID: 9450785 Free article.
[Polycythemia vera: current status of therapy].
Lengfelder E, Hehlmann R. Lengfelder E, et al. Among authors: hehlmann r. Dtsch Med Wochenschr. 2000 Oct 13;125(41):1243-7. doi: 10.1055/s-2000-7728. Dtsch Med Wochenschr. 2000. PMID: 11076265 Review. German. No abstract available.
468 results